---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-015928"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T22:58:45.528656+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Reviva Pharmaceuticals CMO Marc Cantillon resigns effective July 5, 2022

## Summary
- Marc Cantillon resigns as Chief Medical Officer effective July 5, 2022, to pursue other opportunities.
- Resignation not due to disagreements with company operations, policies, or practices.
- Company has commenced search for new clinical management; will use independent consultants in the interim.

## SEC filing metadata
- accession: 0001437749-22-015928
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/0001437749-22-015928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/rvph20220624_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-015928
- JSON: https://secwatch.observer/filing/0001437749-22-015928.json
- Plain text: https://secwatch.observer/filing/0001437749-22-015928.txt

## Key facts
- Executive change
  Marc Cantillon resigned as Chief Medical Officer at REVIVA PHARMACEUTICALS HOLDINGS, INC..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On June 23, 2022, Marc Cantillon, the Chief Medical Officer of Reviva Pharmaceuticals Holdings, Inc. (the “Company”), notified the Company that he will resign as Chief Medical Officer of the Company effective as of July 5, 2022 to pursue additional opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/0001437749-22-015928-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.